according to The Giant Company. Flu shots for the 2024-25 flu and cold season protect individuals against three strains of ...

Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...

Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...

Pfizer stock toppled Friday after the pharma giant reported mixed results for its BioNTech-partnered combination flu and ...

To date, only 17% of Wisconsinites have received a flu shot this season. The DHS and CDC offer vaccine recommendations based ...

I t’s vaccination season, which for most people means getting immunized for flu and COVID-19 (and RSV for infants, pregnant ...

The biopharmaceutical giant, along with its partner BioNTech ... We've just started our phase-three study of a quadrant flu vaccine made out of mRNA. We see it has several advantages over current ...

Every year the flu is different, and every year the vaccine has to be tailored to that moving target of the flu. Because the flu is so pervasive when it goes around and it can be so dangerous ...

in a biotech firm spun out of Oxford University working on novel treatments which include a universal flu vaccine and a therapeutic cancer vaccine. The tech giant’s GV division (formerly known ...

the US drugs giant has said. Pfizer said it was expecting "durable demand" for the vaccine, in a similar way to flu vaccines. In the first three months of 2021, the vaccine generated revenues of $ ...

Both stocks have made significant breakthroughs. Among the qualities a biotech company needs to be successful, being innovative is one of the most important. It's easy to understand why. Although ...

As of this week, individuals at increased risk of infection or flu-related complications are eligible to receive the updated COVID-19 vaccine and flu shot. As of Oct. 28, all individuals six ...